Hamdard, the country’s leading Unani medicine brand, is now preparing to enter a new consumer segment to diversify its products.
Hamdard, the country’s leading Unani drug brand and maker of the popular ‘Ruh Afza’ sherbet, is now gearing up to enter a new consumer segment to diversify its products. The news agency IANS has given this information in a report.
Abdul Majid, chairman of Hamdard Laboratories, was quoted in the report as saying that the company plans to launch a full range of products in the form of face wash, shampoo and oral hygiene products.
“We are currently working on new consumer products, especially those that are easily accepted by the new generation,” Majid said. “We are working on products based on medicinal oils,” he said. Currently, we make at least 26 different types of oils in Unani medicine that have medicinal value. We would like to launch the product in 5 based on this oil. Area
Hamdard also makes ‘Chyavanprash’ with various health supplements. It is developing itself as a company that provides all kinds of healthcare solutions to consumers. To prove the effectiveness of its Unani and herbal medicines, the company is trying to prove their advantages in other formats.
Read more- Multibagger stock: This NBFC stock has enriched in just 20 months, raising Rs 1 lakh to Rs 18 lakh.
Majid said, “Over time you will have to adapt to market trends. So, now we have created our research and development for this. We have good consultants who will help us in developing these products. We started with a R&D. We invest 2 percent of our total turnover in. In the next five years, it will exceed five to six percent on an annual basis and exceed Rs 100 crore. “
Pointing to the power of traditional medicine in increasing immunity to COVID-19 epidemics, Majid said, “Both Ayurvedic and Unani medicine have been very helpful in boosting immunity during the COVID epidemic. In the first wave, the fight against it was led by traditional medicine, which helped people to develop immunity. This fight was later led by vaccines and antivirals, which are now available everywhere. “
